Bayobay, Khalil Kent .

HRN: 21-83-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
12/15/2022
12/17/2022
PO
1.5 Ml
OD
ATP, URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: